| scholarly article | Q13442814 |
| P50 | author | Yong-Tong Zhu | Q88914540 |
| P2093 | author name string | Li Liu | |
| Rui Hua | |||
| Chun-Yan Wang | |||
| Qing-Jun Chu | |||
| Simei Chen | |||
| Song Quan | |||
| Xiaomin Zhan | |||
| P2860 | cites work | Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells | Q33193938 |
| Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine | Q34059854 | ||
| A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line. | Q35031330 | ||
| Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. | Q35928330 | ||
| Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine | Q36278425 | ||
| Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis. | Q36545548 | ||
| Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions | Q36550399 | ||
| Cancer immunoprevention | Q36723234 | ||
| Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. | Q36927352 | ||
| Update on castrate-resistant prostate cancer: 2010. | Q37696938 | ||
| Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology | Q38031924 | ||
| Cancer-related inflammation | Q38066119 | ||
| Therapeutic gene modified cell based cancer vaccines | Q38097182 | ||
| Cancer vaccines: harnessing the potential of anti-tumor immunity. | Q38121282 | ||
| Multiple-purpose immunotherapy for cancer. | Q38665072 | ||
| Advances and perspectives of colorectal cancer stem cell vaccine | Q38665082 | ||
| Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses | Q38800085 | ||
| The granulocyte macrophage-colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer | Q38990500 | ||
| Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity | Q39265240 | ||
| Involvement of ERK and JNK pathways in IFN-γ-induced B7-DC expression on tumor cells | Q39715037 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| BCG vaccination against tuberculosis: past disappointments and future hopes. | Q40947480 | ||
| Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens | Q48564522 | ||
| Prolonged circulation and in vivo efficacy of recombinant human granulocyte colony-stimulating factor encapsulated in polymeric micelles | Q84492212 | ||
| Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs | Q85681837 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| interleukins | Q194908 | ||
| bladder cancer | Q504775 | ||
| immunotherapy | Q1427096 | ||
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 689-697 | |
| P577 | publication date | 2017-02-16 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine | |
| P478 | volume | 6 |
| Q47291286 | PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine | cites work | P2860 |
Search more.